Increased DKA at presentation among newly diagnosed type 1 diabetes patients with or without COVID-19: Data from a multi-site surveillance registry.

Creator(s)

Kara Beliard
Osagie Ebekozien
Carla Demeterco-Berggren
Guy Todd Alonso
Mary Pat Gallagher
Mark A. Clements, Children's Mercy HospitalFollow
Robert Rapaport

Document Type

Article

Publication Date

3-2021

Identifier

DOI: 10.1111/1753-0407.13141

Abstract

Highlights Our multicenter study reports a higher proportion of diabetic ketoacidosis presentation of over 60% in newly diagnosed patients with type 1 diabetes with or without confirmed coronavirus disease 2019 (COVID-19) at diagnosis. This finding is suggestive of delays in seeking care during the COVID-19 pandemic.

Journal Title

J Diabetes

Volume

13

Issue

3

First Page

270

Last Page

272

MeSH Keywords

Adolescent; COVID-19; Child; Child, Preschool; Diabetes Complications; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Female; Humans; Infant; Infant, Newborn; Male; Pandemics; Registries; Sex Factors; Socioeconomic Factors; United States; Young Adult

Keywords

COVID-19; diabetes ketoacidosis; new diagnosis; type 1 diabetes mellitus

Comments

Erratum in

• Corrigendum. [No authors listed]J Diabetes. 2021 Apr;13(4):358. doi: 10.1111/1753-0407.13162.PMID: 33645923 No abstract available.

Recommended Citation

Beliard K, Ebekozien O, Demeterco-Berggren C, et al. Increased DKA at presentation among newly diagnosed type 1 diabetes patients with or without COVID-19: Data from a multi-site surveillance registry [published correction appears in J Diabetes. 2021 Apr;13(4):358]. J Diabetes. 2021;13(3):270-272. doi:10.1111/1753-0407.13141